During the past decade, Ospedale Fatebenefratelli, U.O. di Oncologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Fatebenefratelli, U.O. di Oncologia" are "Ovarian Cancer" (5 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials) and "Endometrial Cancer" (1 trials). Many other conditions were trialed in "Ospedale Fatebenefratelli, U.O. di Oncologia" in a lesser frequency.

Most popular intervention types in "Ospedale Fatebenefratelli, U.O. di Oncologia" are "Drug" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (4 trials), "paclitaxel" (3 trials), "capecitabine" (2 trials), "liposomal doxorubicin" (2 trials) and "docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Fatebenefratelli, U.O. di Oncologia" are 6 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Fatebenefratelli, U.O. di Oncologia". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ospedale Fatebenefratelli, U.O. di Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Fatebenefratelli, U.O. di Oncologia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".